for the progression of chronic kidney disease (CKD) and cardiovascular disease (CVD) in patients with CKD. We examined baseline demographic and clinical characteristics.
T he prevalence of ESRD that requires renal replacement therapy has risen dramatically in the United States during the past three decades (1). Non-dialysis-requiring chronic kidney disease (CKD) is substantially more common than ESRD, with an estimated 15 million adults in the United States having CKD of stage 3 or worse (as defined by an estimated GFR [eGFR] of Ͻ60 ml/min per 1.73 m 2 ) (2) Furthermore, CKD frequently progresses in severity, but the factors that are responsible for accelerated decline need further elucidation. In addition, recent studies have highlighted an important association between even mild CKD and increased risk for cardiovascular disease (CVD) (3), but the mechanisms for this association remain unclear.
In response to the epidemic of CKD and our incomplete understanding of factors that govern its progression and associated morbidity, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) established the Chronic Renal Insufficiency Cohort (CRIC) Study in 2001. The broad
Materials and Methods

Study Organization
The CRIC Study consists of a Scientific and Data Coordinating Center; seven clinical centers, central laboratories, and reading centers; a Scientific Advisory Committee; and NIDDK project scientists as described previously (4) . The study protocol was approved by institutional review boards at participating institutions, and the research was conducted in accordance with the ethical principles of the Declaration of Helsinki.
Study Design
The CRIC Study was designed as a prospective cohort of approximately 3600 participants who were enrolled through seven clinical centers. A weighted random sample of approximately one third of the cohort (referred to as the subcohort) was assigned to undergo additional, more intensive testing (including iothalamate clearance studies to measure GFR and electron-beam tomography) that would also facilitate use of nested case-cohort substudies (4). CRIC participants are followed until death or withdrawal of informed consent. Follow-up continues even after ESRD occurs with initiation of chronic dialysis or receipt of a kidney transplant. Outcomes regarding progression of kidney dysfunction will focus principally on reductions in GFR as well as the occurrence of clinically relevant declines in renal function. Evaluation of subclinical CVD is assessed annually (via standard 12-lead electrocardiography and measurements of ankle-brachial index [ABI]), and transthoracic echocardiography is performed at years 1 and 4 of follow-up for all participants. Coronary artery calcium burden assessment using electron-beam tomography or multidetector computed tomography will be performed in the subcohort at years 1 and 4. Clinical cardiovascular outcomes (including acute myocardial infarction, heart failure, arrhythmias, stroke, and peripheral arterial disease [PAD]) will be ascertained every 6 mo during follow-up, and relevant medical records will be centrally adjudicated. Hypertension at entry was defined as either systolic BP Ն140 mmHg, diastolic BP Ն90 mmHg, or use of antihypertensive medications (5). Diabetes was defined as either fasting glucose Ն126 mg/dl, random glucose Ն200 mg/dl, or use of insulin or antidiabetic medication (6) .
Study Population and Recruitment
Eligibility criteria. The CRIC Study was designed to include a racially and ethnically diverse group of adult patients who were aged 21 to 74 yr and had mild to moderate CKD and approximately half of whom had diabetes (Table 1) . The age and eGFR criteria were specifically designed to facilitate evaluation of the progression and implications of CKD across a wide spectrum of mild to moderate kidney dysfunction and age. Age-based eGFR entry criteria were established to limit the proportion of older individuals who were recruited with age-related diminutions of GFR but otherwise nonprogressive CKD. The level of eGFR used to define eligibility was based on the fourvariable Modification of Diet in Renal Disease (MDRD) estimating equation (7), using locally measured serum creatinine calibrated to the Cleveland Clinic laboratory (8) .
Exclusion criteria. Selected exclusion criteria were implemented (Table 2) . Patients with polycystic kidney disease were excluded because of its distinct pathophysiology and its exclusive focus by another ongoing NIDDK-sponsored study (9) . Patients with additional primary renal diseases were excluded when active immunosuppression had been used within 6 mo of enrollment. Patients with significant coexisting illnesses were also excluded, as detailed in Table 2 .
Recruitment. 
Screening, Enrollment, Follow-up, and Study Data Collection
A total of 5319 participants completed screening visits, at which time consent was obtained and eligibility was determined ( Figure 1 , Table 1 ). Of those screened, 4073 were found to be eligible and 3612 completed a baseline visit, defining membership in the cohort. Five individuals with an eGFR above the exclusion level completed the baseline visit in error and are included in our analyses. At the baseline visit, sociodemographic characteristics, medical history, lifestyle behaviors, and current medications were recorded. Standardized BP measurements were obtained using a previously validated protocol (10) . Anthropometric measures (height, weight, and mid-abdominal waist circumference) were obtained, and body composition was assessed using bioelectrical impedance analysis techniques. ABI was measured using standard methods (11) . A 12-lead electrocardiogram was obtained using standardized methods (12) . GFR was assessed by the renal clearance of 125-iodine iothalamate (13) in the subcohort. As detailed in Table 1 , a series of questionnaires were administered regarding quality of life, diet, cognitive function, depressive symptoms, and physical activity level. Plasma, urine, and nail samples were collected for initial study measures, and aliquots were also stored for future studies. Additional details regarding visit and contact schedule are provided in Table 1 .
Statistical Analysis
The analytical plan for the CRIC Study has been previously described (4). Baseline characteristics are described using means with SD or medians and interquartile ranges for continuous variables, and frequency distribution is described with percentages for categorical variables. Missing values occurred when a participant failed to answer a question on a case report form or when a physical measure was not obtained or a laboratory test was not performed. The analysis for each variable is based on the observed values only. Baseline characteristics are compared between groups using t tests, ANOVA, or 2 tests, as appropriate. A two-sided P Յ 0.05 was considered statistically significant.
Results
Baseline Demographic and Clinical Characteristics of Participants
with diabetes (47%), consistent with the targeted enrollment goals ( Table 3 ). The cohort is racially and ethnically diverse with 1638 (45%) non-Hispanic white patients, 1651 (46%) nonHispanic black/African American patients, 169 (5%) Hispanic patients, and 154 (4%) Asian/Pacific Islander/Native American patients. Approximately 33% of the cohort had completed a college education, and 28% had annual incomes Ͻ$20,000 (US). Nearly 90% of the cohort had a history of hypertension. Fewer than 25% of the cohort had a self-reported history of coronary disease or PAD. Although the mean systolic and diastolic BPs were approximately 128 mmHg and approximately 71 mmHg, respectively, 47% of participants had a baseline BP Ͼ130/80 mmHg at entry. Mean body mass index (BMI) was elevated at 32.1 Ϯ 7.9 kg/m 2 with more than one half of all participants having a BMI Ͼ30 kg/m 2 . Mean eGFR for the entire cohort was 43.4 Ϯ 13.5 ml/min per 1.73 m 2 , and median (IQR) proteinuria was 0.17 g per 24 h (0.07 to 0.81 g per 24 h). Almost 70% of the cohort was taking an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. Most participants had an eGFR consistent with National Kidney Foundation's stages 3 and 4 CKD (70 and 18%, respectively) (14).
Several differences also existed between participants with and without diabetes ( Table 3) . Compared with participants without diabetes, those with diabetes were more likely to be nonwhite and Hispanic and to earn annual incomes Ͻ$20,000 but were less likely to have a college education (P ϭ 0.0001). 
Self-reported myocardial infarction/coronary revascularization, congestive heart failure, and PAD were nearly twice as common among participants with diabetes. Participants with diabetes were also more likely to have a history of hypertension, have mean baseline BP Ͼ130/80 mmHg, and have a BMI Ն30 (P ϭ 0.0001). Furthermore, these participants had a twofold greater prevalence of an ABI Ͻ0.9. Mean eGFR was lower and urine protein higher among participants with diabetes than among those without diabetes.
Baseline Characteristics by eGFR Level
As a result of enrollment strategies, there was relatively even distribution by race across eGFR strata (Table 4 ). In comparison with those who had higher eGFR, participants with lower eGFR tended to older, female, and Hispanic (P ϭ 0.0001). Also, a trend existed between lower eGFR and a higher proportion of annual incomes Ͻ$20,000, having only high school level education, BMI Ͼ30 kg/m 2 , and history of Ͼ100 cigarettes. The prevalence of hypertension (and those with mean BP Ͼ130/80 mmHg), diabetes, CVD, PAD, and proteinuria were also significantly higher in lower eGFR groups (P ϭ 0.0001). With lower eGFR, there were progressive decreases in mean hemoglobin and increases in mean serum phosphorus and total parathyroid hormone (P ϭ 0.0001).
Select Anticipated and Actual Recruitment Targets
Recruitment by racial and ethnic groups was similar to anticipated target goals (Table 5 ). In contrast, the actual recruitment of young participants with (3.99%) and without diabetes (9.51%) was less than the targeted goal of 12.5% for both subgroups (Table 6 ).
Discussion
The CRIC Study was designed to examine risk factors for CKD progression and CVD incidence and progression among a large, representative cohort of individuals with CKD. The CRIC cohort enrolled a diverse set of participants who had CKD and possessed a broad range of kidney dysfunction and other potentially important prognostic attributes. Recruitment goals regarding race/ethnicity, gender, age, and diabetes status were largely met. The strength of the CRIC Study lies in the diverse characteristics of the assembled cohort and the comprehensive data collection activities that have been designed to address gaps in our understanding of CKD-associated morbidity and mortality and to identify potential targets for trials of preventive therapies.
The baseline findings regarding diabetic status and level of kidney function support that the assembled cohort has characteristics representative of the broader CKD population. As expected, participants with diabetes in the cohort were more likely to have self-reported CVD than those without diabetes. (42) 386 (46) 461 (48) 348 (48) 160 (40) non-Hispanic black/African American 303 (45) 387 (46) 430 (44) 319 (44) 202 (51) Hispanic 55 (8) 43 (5) 32 (3) 21 (3) 18 (5) (5) 28 (3) 45 (5) 32 (4) 17 (4) 0.0001 Annual household income (n ͓%͔) 0.1435 Յ$20,000
249 (37) 292 (35) 232 (24) 155 (22) 72 (18) $20,001 to $50,000 179 (27) 199 (24) 267 (28) 162 (23) 96 (24) $50,001 to $100,000
103 (17) 150 (18) 187 (19) 171 (24) 108 (27) Ͼ$100,000
38 (6) 69 (8) 117 (12) 115 (16) 49 (12) no response 93 (14) 134 (16) 165 (17) 117 (16) 72 (18) Educational attainment (n ͓%͔) 0.0001 Ͻ7th grade 27 (4) 15 (2) 10 (1) 4 (1) 2 (1) 7th to 12th grade 126 (18) 160 (19) 143 (15) 82 (11) 27 (7) high school diploma 145 (22) 177 (21) 189 (20) 112 (16) 69 (17) vocational degree 36 (5) 38 (5) 48 (5) 36 (5) 26 (7) some college 162 (24) 224 (27) 228 (24) 192 (27) 112 (28) college graduate 106 (16) 146 (17) 188 (19) 172 (24) 82 (21) graduate degree 65 (10) 84 (10) 162 (17) 122 (17) 76 (19) Tobacco use (n ͓%͔) current smoker 110 (16) 122 (15) 117 (12) 84 (12) (26) 227 (27) 227 (23) 131 (18) 51 (13) 0.0001 chronic heart failure 97 (15) 103 (12) 91 (10) 43 (6) 19 (5) 9.1 Ϯ 0.6 9.2 Ϯ 0. The findings in the CRIC subgroup with diabetes reinforce the findings from clinical trials that indicate that the CVD burden in the ESRD population with diabetes has its beginnings earlier during the course of CKD (15, 16) . In addition, lower levels of eGFR were associated with a greater burden of CVD. This is consistent with the increasing evidence for the presence and severity of CKD as an independent and graded risk factor for CVD events (3) . By using sophisticated measurements of kidney function and subclinical CVD, the CRIC Study will provide insights into the pathophysiology of this relationship and will enable an assessment of both traditional and nontraditional risk factors. Noteworthy is the high prevalence of several potentially modifiable risk factors in this CKD cohort. Almost half of all participants had a BP level above the recommended goal (17) . Suboptimal levels of BP control have been reported in other CKD cohorts (18, 19) , and the findings in the CRIC cohort reinforce the need to raise awareness of effective BP management in CKD as a public health priority. As well, we observed a high prevalence of obesity among participants with and without diabetes. It has been suggested that higher BMI may be an independent risk factor for CKD (20 -22) and progression to ESRD that requires dialysis (23) . The modest association between lower eGFR and previous cigarette exposure is consistent with the previously described association of smoking with CKD (24) . This relationship is also of particular interest because it may represent another potential risk factor. Longitudinal follow-up of CRIC participants will afford a more rigorous assessment of these newly recognized but less studied risk factors on CVD and CKD outcomes.
We also observed an important association between lower eGFR and both lower socioeconomic status (SES) and lesser educational attainment. It is known that lower SES is associated with ESRD (25, 26) . Analyses of several cohorts found an association between lower SES and progressive CKD (27) (28) (29) . The CRIC Study will facilitate evaluation of the impact of SES and educational level in individuals with more advanced stages of CKD and potential mediating pathways that could have important health policy implications.
Previous epidemiologic studies of the relationship between CKD and CVD have come from various sources, including post hoc analyses of clinical trials (30 -33) , large cohort studies focused on non-CKD populations (34 -37), and analyses of large datasets from major health care providers (3, 38) . Despite the important contributions made by these studies, major gaps in our knowledge remain. The CRIC Study will occupy a unique niche because of its use of observational epidemiology in a large cohort of patients with CKD and its use of longitudinal state-of-the-art measurements of kidney function and subclinical CVD. In addition to examining risk factors for CKD and CVD progression, the CRIC Study will facilitate the development of predictive models that identify high-risk groups; the determination of exposure-outcome relationships; and the evaluation of the impact of CKD and progressive CKD on quality of life, functional status, and resource use. Unlike most previous studies, the CRIC Study continues to follow participants after progression to ESRD, thereby providing an important opportunity to study the critical period when patients transition from CKD to ESRD.
Concurrent with the CRIC Study, several ongoing studies are examining risk factors for CKD. The National Health and Nutrition Examination Survey (NHANES) monitors CKD prevalence and risk factors over time (2, 39) . The National Kidney Foundation's Kidney Evaluation Education Program (KEEP) collects data characterizing CKD in the community among at-risk subgroups (40). The African American Study of Kidney Disease and Hypertension (AASK) (41) is investigating factors that influence CKD progression among black individuals with hypertensive kidney disease. Internationally, the CKD-Japan Cohort Study (CKD-JAC) is in the early stages of follow-up. The information gained from the CRIC Study will be complementary to and extend the important work accomplished by these studies. As an example, compared with the populationbased NHANES CKD cohort (2), the CRIC cohort is older and by design has more advanced CKD with more even distribution across eGFR strata, a larger percentage of individuals with diabetes, and a larger representation of black participants to facilitate more robust subgroup analyses.
As with all prospective observational studies, inferences regarding causality will be limited by potential biases and residual confounding. Numerous methodologic strategies have been adopted to minimize these limitations and enhance the robustness of etiologic inferences drawn from this study. Another potential limitation is underrepresentation of young individuals with diabetes. To adapt to this, this group was oversampled for recruitment into the subcohort from which more detailed assessments of kidney function and cardiovascular health will be obtained. In addition, the less-than-anticipated recruitment of Hispanic individuals will be addressed by the ongoing supplemental recruitment of Ͼ330 Hispanic participants at the University of Illinois at Chicago. The observed low level of proteinuria could also have potential implications for future risk of cardiovascular and renal events; however, the high prevalence of self-reported comorbidities suggests that the cohort is at increased risk for adverse events. Furthermore, in the AASK, there was significant progression of CKD despite relatively low levels of baseline proteinuria (42) . It is also important to note that findings from the CRIC Study may not be generalizable to certain types of kidney disease that was poorly represented in the cohort, such as glomerulonephritis. It was not intended for the study to be representative of all patients with CKD; rather, it was designed to be broadly representative of the ESRD population in which diabetes and hypertension are reported as the primary diagnoses for Ͼ70% of patients (1). Finally, analyses included selfreported comorbidities, which are subject to inherent limitations with regard to accuracy.
The CRIC Study has assembled a large and diverse CKD cohort with characteristics that area generalizable to CKD populations managed in different practice settings in the United States. Analogous to the Framingham Heart and Atherosclerosis Risk in Communities Studies, the CRIC Study will use observational epidemiology to answer key questions about the cause, prognosis, management, clinical outcomes, health service use, and quality of life in CKD. The knowledge generated from the CRIC Study will lead to the formulation of hypotheses regarding potentially modifiable pathways that will serve as the basis for targeted interventional trials that focus on reducing the burden of CKD and CVD.
